Danaher Reports First Quarter 2025 Results

Original from: Danaher

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended March 28, 2025.

Key First Quarter 2025 Results

· Net earnings were $1.0 billion, or $1.32 per diluted common share and non-GAAP adjusted diluted net earnings per common share were $1.88.

· Revenues decreased 1.0% to $5.7 billion and non-GAAP core revenue was flat year-over-year.

· Operating cash flow was $1.3 billion and non-GAAP free cash flow was $1.1 billion.

Rainer M. Blair, President and Chief Executive Officer, stated, "Revenue, earnings, and cash flow exceeded our expectations in the first quarter–highlighted by continued momentum in bioprocessing and better-than-expected respiratory demand in our molecular diagnostics business.  Our team also continued to execute very well, leveraging the Danaher Business System to accelerate innovation, drive share gains, and deliver meaningful productivity improvements."

Blair continued, "While the macro backdrop has become more dynamic since the start of the year, it's in times like these that Danaher's positioning and capabilities truly stand out.  We believe that the combination of our team's DBS-driven execution, resilient portfolio and strong balance sheet will continue to differentiate Danaher in 2025 and beyond."

Second Quarter and Full Year 2025 Outlook

The Company provides forecasted sales only on a non-GAAP basis because of the difficulty in estimating the other components of GAAP revenue, such as currency translation, acquisitions and divested product lines.  In addition, we do not reconcile forecasted adjusted diluted net earnings per common share (or components thereof) to the comparable GAAP measure because of the difficulty in estimating the other components (in addition to the items identified in the prior sentence) that would be reflected in any forecasted GAAP diluted net earnings per common share, such as investment gains and losses and discrete tax items.

For the second quarter 2025, the Company anticipates that non-GAAP core revenue will grow low-single digits year-over-year.  For full year 2025, there is no change to the Company's expectation that non-GAAP core revenue will grow approximately 3% year-over-year.  The Company is also initiating full year adjusted diluted net earnings per common share guidance in the range of $7.60 to $7.75.

Source: Danaher Reports First Quarter 2025 Results